OptimizeRx Launches Coronavirus Text Message Alerts
15 März 2020 - 4:30PM
5150 for help. Text STOP to 55150 to cancel. Click here for
terms of use.
Following your signup confirmation, you will begin to receive
CDC-based COVID-19 information:
- Health information and tips, including how to avoid contracting
the virus and symptom warning signs.
- Information on testing and steps you can take to help contain
the spread of COVID-19.
- Regular updates about COVID-19 based on CDC-issued
information.
- Opt-in to alerts and additional opt-ins to continue receiving
alerts and information.
“In order to create the safest health environment possible for
our local communities, it is critical that the public follows the
recommendations of the CDC and other public health agencies,” said
OptimizeRx CEO, William Febbo. “We are providing these CDC alerts
using our digital health network as a public health service for
both consumers and healthcare professionals. With this new COVID-19
Public Alert System, we are hoping to further the knowledge about
this deadly virus for those potentially affected by it, in addition
to the work we’re doing to keep those on the front lines treating
patients informed.”
This new consumer message alert service complements the recently
launched OptimizeRx CDC alert system for healthcare providers. The
company is leveraging its expansive digital network, technology
platform, and partnerships to provide CDC alerts as a public health
service for both consumers and healthcare professionals.
“Easy mobile access to reliable and timely health information
can make a big difference in staying safe and helping to contain
the outbreak,” noted Serge Loncar, head of patient engagement
at OptimizeRx. “We have harnessed the powerful capabilities of our
mobile platform to broadly disseminate critical health information
and updates about the coronavirus so that everyone can better care
for themselves and their loved ones.”
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
digital platform connecting life sciences to the point-of-care,
OptimizeRx provides a direct channel for pharma companies, payers,
medtech, and medical associations to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and Quest,
and directly via its mobile communications platform and digital
therapeutics SaaS platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245 7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both, CMATel
(949) 432-7557 oprx@cma.team
A photo accompanying this announcement is available
here.
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Sep 2023 bis Sep 2024